-
U-73122: From PLC Signaling to Invasion
2026-09-23
U-73122 is a phospholipase C inhibitor for probing calcium signaling, chemotaxis, inflammation, and cancer-cell invasion. This article develops an evidence-based framework for interpreting PLC inhibition as a causal assay variable rather than treating it as a simple endpoint reagent.
-
Okadaic acid (A4540): PP1/PP2A Workflow
2026-09-22
Okadaic acid (A4540) provides a defined way to reduce PP2A-dominant or combined PP1/PP2A serine/threonine phosphatase activity in biochemical and cell-based assays. It is appropriate for phosphorylation, apoptosis, and signal-transduction workflows with matched controls, but biochemical IC50 values should not be treated as universal cellular treatment doses or as evidence of broad phosphatase inhibition.
-
Necrostatin 2: Practical Necroptosis Workflows
2026-09-21
Necrostatin 2 (Nec-2) provides a practical chemical probe for dissecting RIPK2-associated programmed necrotic cell death, with particular value in ischemic stroke research and pathway validation. This guide shows how to prepare, dose, benchmark, and troubleshoot Nec-2 while distinguishing necroptosis from ferroptotic membrane failure.
-
EZ Cap™ Mouse CD80 mRNA: Assay Design
2026-09-21
EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag) enables controlled studies of CD80-dependent co-stimulation. This guide presents a measurement-centered framework that links HA-tag verification, T-cell functional assays, and longitudinal interpretation without overextending published mRNA-immunotherapy findings.
-
Erastin: Designing Interpretable Ferroptosis Assays
2026-09-20
Erastin is a ferroptosis inducer used to investigate how cystine metabolism, glutathione loss, and oncogenic signaling create tumor-cell vulnerability. This guide focuses on assay interpretation, evidence-based controls, and translating ferroptosis research into more defensible cancer biology experiments.
-
Trilaurin (Glycerol Tridodecanoate) Lab Guide
2026-09-19
Trilaurin (Glycerol Tridodecanoate) is a defined C12 triacylglycerol used as a lipid excipient, nonaqueous substrate, and formulation component. This guide covers solvent selection, short-term solution handling, biocatalysis setup, and lipid-particle QC while defining why it is unsuitable for aqueous-only workflows.
-
Mildronate-Derived Lipidoids for Safer mRNA Delivery
2026-09-19
The 2024 ACS Nano study developed mLNP-69, a low-dose lipid nanoparticle incorporating mildronate-derived cationic lipids to preserve mRNA delivery while reducing local inflammation. In prophylactic and therapeutic B16OVA melanoma models, the formulation supported effective cancer-vaccine delivery, providing a preclinical strategy for improving the tolerability of mRNA delivery systems.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-18
Use one transcript to separate cellular delivery from productive translation: Cy5 reports where the mRNA goes, while Firefly Luciferase reports whether it functions. This practical workflow applies the dual reporter to mRNA-LNP screening, trafficking studies, transfection optimization, and imaging assay development.
-
HOXC8 Suppresses Pyroptosis in Lung Cancer
2026-09-18
The reference study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung carcinoma, linking HOXC8 loss to caspase-1-driven pyroptosis rather than conventional apoptosis. Its findings connect HOXC8, HDAC1/2 recruitment, and CASP1 promoter regulation, while providing a mechanistic basis for testing HOXC8-directed RNA interference in lung cancer models.
-
Artesunate B3662: Reliable Cell Assays
2026-09-17
A scenario-based guide to using Artesunate (SKU B3662) in cell viability, proliferation, and cytotoxicity workflows. It connects assay design, solvent control, mechanistic interpretation, and product-quality documentation to improve the reliability of small cell lung carcinoma and related cancer models.
-
Sodium Phosphate Dibasic for Assay Design
2026-09-17
Sodium phosphate dibasic is more than a routine buffer salt: its formulation, ionic effects, and handling can shape assay reproducibility. This guide translates aquatic toxicity evidence into practical buffer-design decisions for biochemical and molecular biology workflows.
-
Copper–Hexetidine Synergy Against Oral Streptococci
2026-09-16
Grytten, Scheie, and Giertsen demonstrated that copper sulfate and hexetidine act synergistically against Streptococcus sobrinus and Streptococcus sanguis in broth culture. The study combines minimum inhibitory concentration testing with growth-curve analysis, providing a quantitative basis for evaluating metal–antiseptic combinations in oral antimicrobial research.
-
Fenofibrate PPARα Agonist Workflows
2026-09-15
Fenofibrate provides a practical bridge between lipid metabolism research, hepatic growth signaling, and cancer biology research. This guide translates PPARα–YAP evidence into reproducible cell, pathway, and animal-study workflows with concentration, solubility, and troubleshooting guidance.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-15
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based workflows, including in situ hybridization and Northern blotting. It is intended for research use only and should not be used for diagnostic, medical, or therapeutic applications.
-
TRIB3, Ferroptosis, and Sunitinib Response in ccRCC
2026-09-14
The reference study identifies TRIB3 as a regulator of sunitinib response in clear cell renal cell carcinoma and links its depletion to ferroptosis through the SLC7A11/GPX4 axis. Its integrated bioinformatic and cellular approach provides a mechanistic rationale for investigating TRIB3 suppression as a strategy to address acquired drug resistance, while remaining preclinical.